Broken hips kill as many women as breast cancer thanks to weakened bones, so why is no one testing those who are most at risk ...

Less than half of patients had undergone bone monitoring, suggesting a need for better clinical guidance and management of ...

Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OS ...

Loss of muscle mass and bone density are two critical issues of aging that disproportionately affect women. Resistance ...

Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe ...

Osteoporosis is typically treated with orally administered drugs, which may take up to a year to have a noticeable effect. A ...

The US Preventative Services Task Force task force recommends against vitamin D supplements for fall and fracture prevention ...

This report highlights the diagnostic challenges of SM, emphasize its underrecognized role in osteoporosis and fragility fractures, and advocates for ...

A new case report was published in Oncoscience's Volume 12 on February 4, 2025, titled “Breaking point: Systemic mastocytosis manifesting as severe osteoporosis.” ...

Explore a rare case of systemic mastocytosis in a young adult, highlighting its role in unexplained osteoporosis and the need ...

AI tech has been developed in the US to enhance clinical bone imaging and decrease osteoporotic fractures in the elderly ...

Bimagrumab, a drug originally developed for muscle loss, may help reduce the risk of osteoporosis in weight loss medication ...